Stevanato Group S.p.A. (STVN)
NYSE: STVNHealth CareMedical/Dental InstrumentsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
STVN stock chart
Technical analysisKey statistics
All statistics- Market cap
- $4.27B
- P/E (TTM)
- 26.53
- Forward P/E
- 21.62
- EPS (TTM)
- $0.59
- Dividend yield
- 0.39% ($0.00)
- Ex-dividend date
- Jun 11, 2026
- 52-week range
- 12.05 – 24.01
- Day range
- 15.35 – 16.15
- Volume / Avg
- 752.32K / 656.22K
- Beta
- —
- Shares outstanding
- 49.83M
52-week range
STVN stock today
Stevanato Group S.p.A. (STVN) closed at $15.65 on Nov 20, down 1.76% (-$0.28), versus the S&P 500's 3.70% decline. Shares are 34.8% below their 52-week high of $24.01, set on Nov 25, 2025 and 29.9% above the 52-week low of $12.05, in the middle of the past year's range. STVN is down 22.2% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 30.1%.
At 26.5x trailing earnings, Stevanato Group S.p.A. trades below the peer-group median of 53.2x. Its forward P/E of 21.6x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.
Summary generated from market data by MetaCap's automated system. Methodology
About Stevanato Group S.p.A.
Company profileStevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Mr. Franco Stevanato
- Headquarters
- Piombino Dese, PD
- Employees
- 6,010
- IPO year
- 2021
- Website
- stevanatogroup.com
Analyst forecast
ForecastConsensus (13 analysts)
buy
Avg. price target
$19.46+24.35%
- Strong buy 3
- Buy 6
- Hold 4
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 3, 2026
- EPS actual vs est.
- $0.16 vs $0.17
- Surprise
- -5.88%
Dividends
Dividend history- Annual dividend
- $0.00
- Dividend yield
- 0.39%
- Last payment
- $0.062
- Ex-dividend date
- Jun 11, 2026
STVN news
All STVN news- Stevanato Group S.p.A. Reports Third Quarter 2026 Financial Results and Outlines 2027 OutlookNasdaq
- Stevanato Group S.p.A. Consensus Price Target Decreased by 21.06% to $20.22Nasdaq
- Stevanato Group S.p.A. Reports Revenue of EUR 326.1 Million for the Three Months Ended September 30, 2026Nasdaq
- Stevanato Group S.p.A. Reports Q3 2026 Revenue of 326 Million EurosNasdaq
- Stevanato Group S.p.A. Reports 8% Revenue Growth for the Third Quarter of Fiscal 2026NasdaqSTVN, WSO.B
- Stevanato Group Delivers 8% Revenue Growth for the Third Quarter of Fiscal 2026Business Wire
- Stevanato Group to Report Third Quarter 2026 Financial Results on November 3, 2026Business Wire
- Stevanato Group is Now Oversold (STVN)Nasdaq
Stevanato Group S.p.A. peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ICUIICU Medical Inc. | 172.52 | -1.84% | $4.31B | vs STVN |
| MMEDMiniMed Group Inc. | 16.01 | -1.54% | $4.50B | vs STVN |
| HTFLHeartflow Inc. | 46.69 | +4.62% | $4.10B | vs STVN |
| NVSTEnvista Holdings Corporation | 22.91 | -1.55% | $3.67B | vs STVN |
| MMSIMerit Medical Systems Inc. | 84.34 | -0.08% | $5.05B | vs STVN |
| PLSEPulse Biosciences Inc | 45.55 | +2.57% | $3.35B | vs STVN |
| HAEHaemonetics Corporation | 120.16 | -0.17% | $5.47B | vs STVN |
| IRTCiRhythm Holdings Inc. | 94.72 | +0.51% | $3.18B | vs STVN |
Indexes, lists and sector
Stevanato Group S.p.A. stock FAQ
What is Stevanato Group S.p.A.'s stock price today?
STVN last traded at $15.65 as of Nov 20, 4:00 PM EST, down 1.76% on the day. Prices are delayed at least 15 minutes.
Does Stevanato Group S.p.A. pay a dividend?
Yes. Stevanato Group S.p.A. pays $0.00 per share annually, a 0.39% yield. The most recent dividend of $0.062 had an ex-dividend date of Jun 11, 2026.
What is STVN's P/E ratio?
STVN trades at a trailing P/E ratio of 26.53 and a forward P/E of 21.62, compared with a median of 53.2 for its closest peers.
Who is Stevanato Group S.p.A.'s CEO?
Mr. Franco Stevanato is the chief executive officer of Stevanato Group S.p.A., which has about 6,010 employees.
What is the STVN 52-week high?
The 52-week high for STVN is $24.01 and the 52-week low is $12.05. The stock is currently 34.8% below its high.